Lumenis MOSES Technology Wins 2020 MedTech Breakthrough Award For Innovation In Surgical Technology

Lumenis Ltd., the world's largest energy-based medical device company for aesthetic, surgical and ophthalmic applications, announced today that MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, has selected Lumenis' MOSES™ technology Holmium Laser platform as the winner of its "Best New Surgical Technology Solution" award in the fourth annual MedTech Breakthrough Awards program.Used for a variety of urological indications, including kidney stone and BPH treatments, MOSES™ is a patent-protected pulse delivery technology that remarkably improves energy transmission, resulting in more efficient and faster procedures. Through a proprietary combination of holmium laser systems and fibers, MOSES™ technology optimizes laser energy transmission to increase stone ablation volume while reducing dependency on the working distance between the fiber and stone. In BPH MOSES™ unique pulse modulation allows for shorter and more efficient procedures, resulting in greater case volume while releasing patients home the same day.[3] MOSES, chosen by 85% of the US Honor Roll List hospitals as their Urology laser platform of choice,[1] is the only new laser platform that was proven to improve procedural outcomes in a double-blind randomized clinical trial – showing 20% faster procedural time compared to the standard laser technology.[2] The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Robotics, Clinical Administration, Telehealth, Patient Engagement, Electronic Health Records (EHR), mHealth, Medical Devices, Medical Data and many more. This year's program attracted more than 3,750 nominations from over 15 different countries throughout the world. "MOSES™ technology embodies the spirit of the MedTech Breakthrough Awards with impressive technological innovation that represents a true advancement in surgical technology," said James Johnson, managing director, MedTech Breakthrough. "Lumenis' MOSES technology is helping surgeons around the world to provide better treatments for their patients, with tangible advantages over standard technologies. We are thrilled to name the Company a 2020 MedTech Breakthrough Award winner." Having introduced the first holmium laser for the treatment of urinary stones and BPH more than 30 years ago, Lumenis continues to push the boundaries of urology care and is a leader in urology care innovation. In collaboration with the leading research and teaching institutions worldwide, Lumenis looks to continue and enhance its surgical solutions – providing better technology for better patient care.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!